Gabapentin Capsule
Product Images NDC 71205-766

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-766). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71205-766-90 (Gabapentin 300mg 30s)

71205-766-90 (Gabapentin 300mg 30s)
Gabapentin 300mg capsules, packaged by Proficient Rx LP, are prescription medication intended for oral consumption only. Each bottle contains 90 gabapentin capsules of 300mg strength, with the National Drug Code (NDC) 71205-766-90 and lot number 00000. The medication is manufactured by ScieGen Pharmaceuticals, Inc. The gabapentin capsules are white to off-white powder filled in size "1" hard gelatin capsules with opaque yellow colored cap and body. SG is imprinted on the cap, 180 on body with black ink, and the label further bears information on medication guide, expiration date, product ID, GTIN, and storage instructions. The medication should be kept out of the reach of children.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
This appears to be a table showing "Mean Pain Score" for two different treatment groups (placebo and gabapentin) over the course of several weeks. The table also notes the dosage regimen for each treatment group (titration for Parkod and fixed for Wesk). The did not provide any further useful text to describe the context of this table.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This appears to be a chart or graph showing the results of a study on the effectiveness of different doses of gabapentin for pain management. The chart shows the average pain score over a period of 7 weeks, with a baseline score at week 1. The three different doses of gabapentin are compared to a placebo. The text is readable.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
FDA Label Image

Cockcroft And Gault Equation (Image 04)

Cockcroft And Gault Equation (Image 04)
FDA Label Image

Gabapentin Structural Formula (Image 05)

Gabapentin Structural Formula (Image 05)
FDA Label Image

Image-09 (Image 09)

Image-09 (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.